Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Among the analyses of cell surface receptors, we found that proliferative ability of human iPS cell-derived hepatic progenitor-like cells (HPCs) was significantly induced by addition of both Epidermal Growth Factor(EGF) and Neuregulin1(NRG1). Moreover, we revealed that HPCs maintained high proliferative ability on the human laminin-511 fragments as substitute for culturing on mouse embryonic fibroblasts (MEFs) as feeder cells. Based on these results, we established stably and long-term expansion culture system of human iPS cell-derived HPCs.
|